Welcome

InDex Pharmaceuticals AB discovers and develops DIMS drugs (DNA-based immunomodulatory sequence) to treat diseases within a variety of therapeutic areas, including inflammation and cancer, which affect millions of people around the world.

With our innovative therapeutic approach, the ambition is to improve the quality of life for these patients.

InDex Diagnostics novel technology focuses on multi-gene analysis, which enables healthcare professionals to improve gastrointestinal disease classification and avoid non-effective, and potentially risky, drug treatments.